ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag viral latency immunology culture

T Cells and Neurons Talk to Each Other
Ashley Yeager | Oct 1, 2020 | 10+ min read
Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.
Two-Faced Proteins May Tackle HIV Reservoirs
Amanda B. Keener | Oct 21, 2015 | 3 min read
Researchers design antibody-like proteins to awaken and destroy HIV holdouts.
False-colored micrograph of Mycobacterium tuberculosis
Tuberculosis: The Forgotten Pandemic
Anthony King | Jul 1, 2021 | 10+ min read
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon.
Research Notes
Eugene Russo | Jun 25, 2000 | 5 min read
Putting Polio to Good Use Add polio to a host of other viral and bacterial foes that, in modified forms, could prove therapeutically beneficial. Although Russian scientists attempted to use polio to treat cancer in the 1960s--unpublished experiments about which little is known--a recent brain cancer study in mice is the first modern-day attempt to harness the power of the virus (M. Gromeier et al., "Intergeneric poliovirus recombinants for the treatment of malignant glioma," Proceedings of the
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Week in Review: October 21–25
Tracy Vence | Oct 25, 2013 | 4 min read
PubMed launches Commons; measuring HIV’s latent reservoir; immune-related pathway variation in genome, microbiome; rapamycin and flu vaccines; grasshopper mice resistant to pain
Does Multiple Sclerosis Have a Herpesvirus Connection?
Douglas Steinberg | May 1, 2000 | 9 min read
Editor's Note: This is the second of two articles on the difficulties of proving that a virus contributes to a disease. The first article, on mouse mammary tumor virus and human breast cancer, appeared in the April 17 issue of The Scientist.1 Donald R. Carrigan and Konstance K. Knox Someone once said that if you want to ruin your reputation, go into MS [multiple sclerosis] research, quips Jacqueline E. Friedman, a senior research associate at Rockefeller University. But Friedman, who deals wit
The Jon Yewdell Selection
Jon Yewdell | Apr 6, 2003 | 3 min read
My Top 5 | The Jon Yewdell Selection Courtesy of Jon Yewdell 1. In the now distant year of 1970, the physical nature of the plasma membrane (or any membrane for that matter) was uncertain. Frye and Edidin used Sendai virus to fuse human and mouse cell, then stained the cells with fluorochrome-labeled antibodies specific for human or mouse antigens.1 They watched the unfolding drama in a fluorescent microscope as the human and mouse proteins completely mixed in real time, providing an elega
Macro, Mini, Micro
Carina Storrs | Jan 1, 2013 | 7 min read
Clever microfluidic platforms take the study of protein-protein interactions to a new level.
Master of the Cell
Judy Lieberman | Apr 1, 2010 | 10+ min read
By Judy Lieberman Master of the Cell RNA interference, with its powerful promise of therapy for many diseases, may also act as a master regulator of most—if not all—cellular processes. RNA silencing. Computer artwork showing a length of RNA (yellow with red rings) bound to an RNA-induced silencing complex (RISC). © Medi-Mation Ltd / Photo Researchers, Inc. ne of the biggest surprises in biology in the past d

Run a Search

ADVERTISEMENT